431
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Pregnancy outcomes associated with an abnormal 50-g glucose screen during pregnancy: a systematic review and Meta-analysis

ORCID Icon, , , &
Pages 4132-4140 | Received 06 Aug 2019, Accepted 16 Dec 2019, Published online: 01 Jan 2020

References

  • Tward C, Barrett J, Berger H, et al. Does gestational diabetes affect fetal growth and pregnancy outcome in twin pregnancies?. Am J Obstet Gynecol. 2016;214(5):653.e1–653.e8.
  • Peterson C, Grosse SD, Li R, et al. Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States. Am J Obstet Gynecol. 2015;212(1):74.e1–74.e9.
  • HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
  • Retnakaran R, Qi Y, Sermer M, et al. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care. 2008;31(10):2026–2031.
  • Silverman BL, Rizzo TA, Cho NH, et al. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care. 1998. 21(Suppl 2):B142–B149.
  • Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med. 2004;21(2):103–113.
  • Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 190. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018. 131(2):e49–e64.
  • O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278–285.
  • Roeckner JT, Sanchez-Ramos L, Jijon-Knupp R, et al. Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;215(3):287–297.
  • Akgol S, Budak MS. Obstetric and neonatal outcomes of pregnancies with mild gestational hyperglycemia diagnosed at gestational diabetes mellitus screening. Gynecol Obstet Reprod Med. 2018;25:138–141.
  • Ayhan S, Altinkata SO, Gungor T, et al. Prognosis of pregnancies with different degrees of glucose intolerance. Matenal-Fetal Med. Perinatol. 2013;1:76–81.
  • Biri A, Korucuoglu U, Ozcan P, et al. Effect of different degrees of glucose intolerance on maternal and perinatal outcomes. J Matern Fetal Neonatal Med. 2009;22(6):473–478.
  • Bo S, Menato G, Gallo ML, et al. Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand. 2004;83(4):335–340.
  • Dudhbhai M, Lim L, Bombard A, et al. Characteristics of patients with abnormal glucose challenge test and normal oral glucose tolerance test results: comparison with normal and gestational diabetic patients. Am J Obstet Gynecol. 2006;194(5):e42–e45.
  • Ertunc D, Tok E, Dilek U, et al. The effect of carbohydrate intolerance on neonatal birth weight in pregnant women without gestational diabetes mellitus. Ann Saudi Med. 2004;24(4):280–283.
  • Figueroa D, Landon MB, Mele L, et al. Relationship between 1-hour glucose challenge test results and perinatal outcomes. Obstet Gynecol. 2013;121(6):1241–1247.
  • Forest JC, Massé J, Garrido-Russo M. Glucose tolerance test during pregnancy: the significance of one abnormal value. Clin Biochem. 1994;27(4):299–304.
  • Gumus II, Turhan NO. Are patients with positive screening but negative diagnostic test for gestational diabetes under risk for adverse pregnancy outcome?. J Obstet Gynaecol Res. 2008;34(3):359–363.
  • Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol. 2003;102(4):850–856.
  • Ho TC, Yan YH, Lu MC, et al. Influence of medical nutrition therapy on borderline glucose intolerance in pregnant Taiwanese women. J Matern Fetal Neonatal Med. 2016;29(7):1181–1186.
  • Kaufmann RC, McBride P, Amankwah KS, et al. The effect of minor degrees of glucose intolerance on the incidence of neonatal macrosomia. Obstet Gynecol. 1992;80(1):97–101.
  • Keskin U, Ercan CM, Güngör S. The effects of gestational diabetes mellitus screening and diagnostic tests on fetal macrosomia. Perinatal J. 2013;21(3):133–137.
  • Kokanalı MK, Tokmak A, Kaymak O, et al. The effect of treatment on pregnancy outcomes in women with one elevated oral glucose tolerance test value. Ginekol Pol. 2014;85(10):748–753.
  • Leikin EL, Jenkins JH, Pomerantz GA, et al. Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomia. Obstet Gynecol. 1987;69(4):570–573.
  • Lindsay MK, Graves W, Klein L. The relationship of one abnormal glucose tolerance test value and pregnancy complications. Obstet Gynecol. 1989;73(1):103–106.
  • McLaughlin GB, Cheng YW, Caughey AB. Women with one elevated 3-hour glucose tolerance test value: are they at risk for adverse perinatal outcomes?. Am J Obstet Gynecol. 2006;194(5):e16–e19.
  • Melamed N, Hiersch L, Hod M, et al. Is abnormal 50-g glucose-challenge testing an independent predictor of adverse pregnancy outcome?. J Matern Fetal Neonatal Med. 2012;25(12):2583–2587.
  • Naylor CD, Sermer M, Chen E, et al. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto trihospital gestational diabetes investigators. JAMA. 1996;275(15):1165–1170.
  • Pugh SK, Poole AT, Hill JB, et al. Abnormal 1 hour glucose challenge test followed by a normal 3 hour glucose tolerance test: does it identify adverse pregnancy outcome?. J Miss State Med Assoc. 2010;51(1):3–6.
  • Stamilio DM, Olsen T, Ratcliffe S, et al. False-positive 1-hour glucose challenge test and adverse perinatal outcomes. Obstet Gynecol. 2004;103(1):148–156.
  • Temming LA, Tuuli MG, Stout MJ, et al. Maternal and perinatal outcomes in women with insulin resistance. Amer J Perinatol. 2016;33(8):776–780.
  • Thanasuan S, Borriboonhirunsarn D. Incidence of gestational diabetes mellitus among pregnant women with one abnormal value of oral glucose tolerance test. J Med Assoc Thai. 2006;89(8):1109–1114.
  • Vambergue A, Nuttens MC, Verier-Mine O, et al. Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The diagest study. Diabet Med. 2000;17(3):203–208.
  • Wang CS, Wei YM, Yang HX. Analysis of the effects of gestational diabetes mellitus based on abnormal blood glucose on pregnancy outcomes. Chinese Journal of Contemporary Pediatrics. 2013;48(12):899–902.
  • Wang H, Zhang W, Ma JR, et al. Effect of impaired glucose tolerance during pregnancy on newborns. Chinese Journal of Contemporary Pediatrics. 2009;11(3):177–180.
  • Yee LM, Cheng YW, Liddell J, et al. 50-Gram glucose challenge test: is it indicative of outcomes in women without gestational diabetes mellitus?. J Matern Fetal Neonatal Med. 2011;24(9):1102–1106.
  • Yesildager E, Koken G, Gungor AN, et al. Perinatal outcomes of borderline diabetic pregnant women. J Obstet Gynaecol. 2014;34(8):666–668.
  • Yogev Y, Langer O, Xenakis EM, et al. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonatal Med. 2005;17(1):29–34.
  • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
  • The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hospital Research Institute. [cited 2018 Oct 20]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • IntHout J, Ioannidis JP, Rovers MM, et al. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6(7):e010247.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
  • Breslow NE, Day NE. Statistical methods in cancer research. Volume I – the analysis of case-control studies. IARC Sci Publ. 1980;32:5–338.
  • L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107(2):224–233.
  • Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Landon MB, Mele L, Spong CY, et al. The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol. 2011;117(2, Part 1):218–224.
  • Ehrlich SF, Crites YM, Hedderson MM, et al. The risk of large for gestational age across increasing categories of pregnancy glycemia. Am J Obstet Gynecol. 2011;204(3):240.e1–240.e6.
  • Karachaliou M, Georgiou V, Roumeliotaki T, et al. Association of trimester-specific gestational weight gain with fetal growth, offspring obesity, and cardiometabolic traits in early childhood. Am J Obstet Gynecol. 2015;212(4):502.e1–502.14.
  • Lesseur C, Armstrong DA, Paquette AG, et al. Maternal obesity and gestational diabetes are associated with placental leptin DNA methylation. Am J Obstet Gynecol. 2014;211(6):654.e1–654.e9.
  • Wright CS, Rifas-Shiman SL, Rich-Edwards JW, et al. Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens. 2009;22(2):215–220.
  • Sridhar SB, Darbinian J, Ehrlich SF, et al. Maternal gestational weight gain and offspring risk for childhood overweight or obesity. Am J Obstet Gynecol. 2014;211(3):259.e1–259.e8.
  • Committee on Practice Bulletins – Obstetrics. Practice Bulletin No 178: shoulder dystocia. Obstet Gynecol. 2017. 129(5):e123–e133.
  • Garner PR, D'Alton ME, Dudley DK, et al. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol. 1990;163(2):505–508.
  • Roberts R. Hypertension in women with gestational diabetes. Diabetes Care. 1998;21(Suppl 2):B27–B32..
  • Carr DB, Newton KM, Utzschneider KM, et al. Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia. Hypertens Preg. 2011;30(2):153–163.
  • Di Cianni G, Seghieri G, Lencioni C, et al. Normal glucose tolerance and gestational diabetes mellitus: what is in between? Diabetes Care. 2007;30(7):1783–1788.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.